Upload Avatar (500 x 500)
Sun Lingyun
Medical School
Nanjing University
Jiangsu
Language: Chinese, English
Systemic Lupus Erythematosus
Pathogenesis
Autoimmune Diseases
Mesenchymal Stem Cells
Therapy
Clinical Application
Research
Stem Cell Transplantation
Immunology
Inflammation
Areas of Focus
- Pathogenesis of Systemic Lupus Erythematosus
- Mesenchymal Stem Cell Therapy for Autoimmune Diseases
Academic Background & Achievements
- 1998: First in Asia to successfully use autologous bone marrow stem cell therapy for severe refractory lupus erythematosus
- 2007: First in the world to use allogeneic mesenchymal stem cell therapy for lupus erythematosus and other autoimmune diseases
- Published 505 papers, including 211 SCI papers with a cumulative impact factor of 1138
- Chief of National Key R&D Program
- Published in journals like Cell Stem Cell, Immunity, Nat Commun, Stem Cells, Ann Rheum Dis, Nat Rev Rheumatol, Blood, Gut
Publications
- Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis, Not mentioned, 2017
- Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis, Not mentioned, 2019
- Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: A long-term retrospective study, Not mentioned, 2018
- Mesenchymal stem cells inhibited the differentiation of MDSCs via COX2/PGE2 in experimental sialadenitis, Not mentioned, 2020
- Mesenchymal stem cell transplantation ameliorates Sjögren's syndrome via suppressing IL-12 production by dendritic cells, Not mentioned, 2018
- Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9, Not mentioned, 2018
- Response to: 'Correspondence on 'Incidence trend of five common musculoskeletal disorders from 1990 to 2017 at the global, regional and national level: results from the Global Burden of Disease study 2017' by Chiang et al., Not mentioned, 2020
- Mesenchymal stem cell therapy induces FLT3L and CD1c+ dendritic cells in systemic lupus erythematosus patients, Not mentioned, 2019
Awards
- 2019: National Science and Technology Award, Second Prize for Invention
- 2013: Jiangsu Science and Technology Progress Award, First Prize
- 2019: Jiangsu Medical Science and Technology Award, International Science and Technology Cooperation Award
- 2018: Jiangsu Medical Science and Technology Award, International Science and Technology Cooperation Award
- 2018: Jiangsu Medical Award, Second Prize
- 2018: Chinese Research Hospital Association Medical Achievement Transformation Award
- 2016: Jiangsu Medical New Technology Introduction Award, First Prize
- 2014: Ministry of Education Higher Education Science and Technology Progress Award, Second Prize
- 2013: Chinese Medical Award, Second Prize
- 2013: Jiangsu Medical Award, First Prize
- 2013: Nanjing Science and Technology Progress Award, First Prize
- 2011: Jiangsu Science and Technology Progress Award, Third Prize
- 2009: Jiangsu Science and Technology Progress Award, Second Prize
- 2009: Jiangsu New Technology Introduction Special Award
- 2009: Nanjing Science and Technology Progress Award, First Prize
- 2008: Nanjing New Technology Introduction Award, First Prize
